131 related articles for article (PubMed ID: 37855183)
21. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
[TBL] [Abstract][Full Text] [Related]
22. C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma.
Zhu JJ; Jillette N; Li XN; Cheng AW; Lau CC
Acta Neuropathol; 2020 Dec; 140(6):951-960. PubMed ID: 32909151
[TBL] [Abstract][Full Text] [Related]
23. Supratentorial ependymoma with YAP1:FAM118B fusion: A case report.
Wang J; Wang L; Fu L; Li QC; Qiu XS; Wang EH; Yu JH
Neuropathology; 2021 Apr; 41(2):133-138. PubMed ID: 33480048
[TBL] [Abstract][Full Text] [Related]
24. L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors.
Aboubakr O; Metais A; Berthaud C; Gigant P; Mehdi L; Pucelle N; Lacombe J; Hasty L; Chrétien F; Lechapt E; Varlet P; Tauziède-Espariat A
J Neuropathol Exp Neurol; 2022 Jan; 81(1):82-85. PubMed ID: 35062030
[No Abstract] [Full Text] [Related]
25. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
[TBL] [Abstract][Full Text] [Related]
26. ZFTA (Zinc Finger Translocation Associated) Fusion in Supratentorial Ependymomas: Low Prevalence in South Asians and No Correlation with Survival.
Goyal-Honavar A; Balasundaram A; Thayakaran IP; Babu M; Pai R; Joseph J; Jayachandran R; Chacko AG; Mathew LG; Balakrishnan R; Rajshekhar V; Jeyaseelan L; Sudarsanam TD; Chacko G
World Neurosurg; 2022 Aug; 164():e82-e90. PubMed ID: 35378317
[TBL] [Abstract][Full Text] [Related]
27. [Verification of the diagnosis of supratentorial ependymomas by real-time PCR].
Galstyan SA; Telysheva EN; Lavrinovich AO; Shaikhaev EG; Snigireva GP; Petrova EI; Gorelyshev SK; Zheludkova OG; Kushel YV; Kumirova EV; Ryzhova MV
Arkh Patol; 2023; 85(3):5-11. PubMed ID: 37272434
[TBL] [Abstract][Full Text] [Related]
28. C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcoma.
Cachia D; Wani K; Penas-Prado M; Olar A; McCutcheon IE; Benjamin RS; Armstrong TS; Gilbert MR; Aldape KD
Brain Tumor Pathol; 2015 Apr; 32(2):105-11. PubMed ID: 25388523
[TBL] [Abstract][Full Text] [Related]
29. A clinicopathological analysis of supratentorial ependymoma, ZFTA fusion-positive: utility of immunohistochemical detection of CDKN2A alterations and characteristics of the immune microenvironment.
Hashimoto N; Suzuki T; Ishizawa K; Nobusawa S; Yokoo H; Nishikawa R; Yasuda M; Sasaki A
Brain Tumor Pathol; 2023 Jul; 40(3):163-175. PubMed ID: 37322295
[TBL] [Abstract][Full Text] [Related]
30. Magnetic Resonance Imaging Features of Zinc Finger Translocation Associated-RELA Fusion Ependymoma Compared to Its Wild-Type Counterpart.
Shao H; Chen N; Su X; Zheng L; Yang X; Wan X; Zhang S; Tan Q; Li S; Gong Q; Yue Q
World Neurosurg; 2023 Jul; 175():e1283-e1291. PubMed ID: 37149089
[TBL] [Abstract][Full Text] [Related]
31. Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment.
Träger M; Schweizer L; Pérez E; Schmid S; Hain EG; Dittmayer C; Onken J; Fukuoka K; Ichimura K; Schüller U; Dührsen L; Müther M; Paulus W; Thomas C; Gutt-Will M; Schucht P; Maragkou T; Schittenhelm J; Eckert F; Niyazi M; Fleischmann DF; Dorostkar MM; Feyer P; May SA; Moskopp D; Badakhshi H; Radke C; Walter J; Ehret F; Capper D; Kaul D
Neuro Oncol; 2023 Jul; 25(7):1286-1298. PubMed ID: 36734226
[TBL] [Abstract][Full Text] [Related]
32. Infratentorial C11orf95-fused gliomas share histologic, immunophenotypic, and molecular characteristics of supratentorial RELA-fused ependymoma.
Keenan C; Graham RT; Harreld JH; Lucas JT; Finkelstein D; Wheeler D; Li X; Dalton J; Upadhyaya SA; Raimondi SC; Boop FA; DeCuypere M; Zhang J; Vinitsky A; Wang L; Chiang J
Acta Neuropathol; 2020 Dec; 140(6):963-965. PubMed ID: 33099686
[No Abstract] [Full Text] [Related]
33. Targeting fibroblast growth factor receptors to combat aggressive ependymoma.
Lötsch D; Kirchhofer D; Englinger B; Jiang L; Okonechnikov K; Senfter D; Laemmerer A; Gabler L; Pirker C; Donson AM; Bannauer P; Korbel P; Jaunecker CN; Hübner JM; Mayr L; Madlener S; Schmook MT; Ricken G; Maaß K; Grusch M; Holzmann K; Grasl-Kraupp B; Spiegl-Kreinecker S; Hsu J; Dorfer C; Rössler K; Azizi AA; Foreman NK; Peyrl A; Haberler C; Czech T; Slavc I; Filbin MG; Pajtler KW; Kool M; Berger W; Gojo J
Acta Neuropathol; 2021 Aug; 142(2):339-360. PubMed ID: 34046693
[TBL] [Abstract][Full Text] [Related]
34. Ependymoma with C11orf95-MAML2 fusion: presenting with granular cell and ganglion cell features.
Tamai S; Nakano Y; Kinoshita M; Sabit H; Nobusawa S; Arai Y; Hama N; Totoki Y; Shibata T; Ichimura K; Nakada M
Brain Tumor Pathol; 2021 Jan; 38(1):64-70. PubMed ID: 33221956
[TBL] [Abstract][Full Text] [Related]
35. Ependymoma associated protein Zfta is expressed in immature ependymal cells but is not essential for ependymal development in mice.
Herranz-Pérez V; Nakatani J; Ishii M; Katada T; García-Verdugo JM; Ohata S
Sci Rep; 2022 Jan; 12(1):1493. PubMed ID: 35087169
[TBL] [Abstract][Full Text] [Related]
36. Review of ependymomas: assessment of consensus in pathological diagnosis and correlations with genetic profiles and outcome.
Sasaki A; Hirato J; Hirose T; Fukuoka K; Kanemura Y; Hashimoto N; Kodama Y; Ichimura K; Sakamoto H; Nishikawa R
Brain Tumor Pathol; 2019 Apr; 36(2):92-101. PubMed ID: 30929114
[TBL] [Abstract][Full Text] [Related]
37. Low-dose Actinomycin-D treatment re-establishes the tumoursuppressive function of P53 in RELA-positive ependymoma.
Tzaridis T; Milde T; Pajtler KW; Bender S; Jones DT; Müller S; Wittmann A; Schlotter M; Kulozik AE; Lichter P; Peter Collins V; Witt O; Kool M; Korshunov A; Pfister SM; Witt H
Oncotarget; 2016 Sep; 7(38):61860-61873. PubMed ID: 27556362
[TBL] [Abstract][Full Text] [Related]
38. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
39. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor.
Lim KY; Lee KH; Phi JH; Yun H; Won JK; Choi SH; Park SH
Brain Pathol; 2022 Jan; 32(1):e13020. PubMed ID: 34506076
[TBL] [Abstract][Full Text] [Related]
40. Utility of copy number variants in the classification of intracranial ependymoma.
Evenson M; Cai C; Hucthagowder V; McNulty S; Neidich J; Kulkarni S; Dahiya S
Cancer Genet; 2020 Jan; 240():66-72. PubMed ID: 31794935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
